“…Based on 3C and 3D (3CD) junction region nucleotide sequences, AiVs are currently classified into three genetically distinct genotypes (A to C) (2,25). They have been identified in Asian (14,15,23,26,27), European (2,7,12,13,16,17), South American (13), and African (19,20) countries, suggesting their worldwide distribution. Seroprevalence studies performed in several countries demonstrated a high percentage (80 to 99%) of AiV antibodies in adults (3,13,18,21,24), indicating widespread human exposure.…”